Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Corvus Pharma Com (NQ: CRVS )

2.850 USD UNCHANGED
Streaming Delayed Price Updated: 5:54 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Corvus Pharma Com

< Previous 1 2 3 4 Next >
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
From GlobeNewswire News Releases
Thinking about buying stock in Avinger, Rigel Pharmaceuticals, Vistagen Therapeutics, Bio-Path, or Corvus Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for AVGR, RIGL, VTGN, BPTH, and CRVS. 
From PR Newswire
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
From GlobeNewswire News Releases
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
From GlobeNewswire News Releases
Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & Exposition
From GlobeNewswire News Releases
Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition
Includes updated data from CPI-818 phase 1/1b trial and pre-clinical results supporting use in autoimmune lymphoproliferative syndrome (ALPS) 
From GlobeNewswire News Releases
Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
From GlobeNewswire News Releases
Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From GlobeNewswire News Releases
Corvus Pharmaceuticals COVID-19 Abstract Selected for “Hot Topic” Oral Session at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Company to host R&D Symposium webcast on November 12, 2020 at 11:00 am ET to highlight COVID-19 program and provide updates on its cancer programs 
From GlobeNewswire News Releases
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Corvus Pharmaceuticals to Present Updated Data from its Clinical Trial of CPI-006 for Patients with COVID-19 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Company to host R&D Symposium webcast November 12, 2020 at 11:00 am ET to highlight COVID-19 program and provide updates on its cancer programs 
From GlobeNewswire News Releases
Thinking about buying stock in Enlivex Therapeutics, Corvus Pharmaceuticals, Livent Corp, Solid Biosciences, or Boxlight Corp?
InvestorsObserver issues critical PriceWatch Alerts for ENLV, CRVS, LTHM, SLDB, and BOXL. 
From PR Newswire
Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
From GlobeNewswire News Releases
New Data from Corvus Phase 1 Study of CPI-006 Continues to Support its Potential as a Treatment for COVID-19
From GlobeNewswire News Releases
New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020
From GlobeNewswire News Releases
Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors
Dr. Mitchell adds significant experience in cancer care, research and healthcare delivery as the Company advances pipeline into later-stage clinical development 
From GlobeNewswire News Releases
Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19
From GlobeNewswire News Releases
Corvus Announces Participation in Upcoming Investor Conferences
From GlobeNewswire News Releases
Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
From GlobeNewswire News Releases
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT 
From GlobeNewswire News Releases
Unprecedented Collaboration Formed To Create Vaccine Against COVID-19
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Unprecedented Collaboration Formed to Create Vaccine Against COVID-19
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about buying stock in Annovis Bio, Corvus Pharmaceuticals, MGM Resorts, PDS Biotechnology, or Remark Holdings?
InvestorsObserver issues critical PriceWatch Alerts for ANVS, CRVS, MGM, PDSB, and MARK. 
From PR Newswire
Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19
From GlobeNewswire News Releases
Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant
From GlobeNewswire News Releases
Corvus Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback